Data supporting the figures in our Nature Partner Journal (NPJ) Breast Cancer paper:

*Robust and Interpretable PAM50 Reclassification Exhibits Survival Advantage for Myoepithelial and Immune Phenotypes*

James C Mathews, Saad Nadeem, Arnold J Levine, Maryam Pouryahya, Joseph O Deasy, Allen Tannenbaum.
